mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
0.01 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
AP-24534 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
gossypol |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
EHT 1864 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.01 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |